trending Market Intelligence /marketintelligence/en/news-insights/trending/SXmklK8XAer-njJUyhKivw2 content esgSubNav
In This List

Tianda Pharmaceuticals director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Tianda Pharmaceuticals director resigns

SHI Shaobin resigned as nonexecutive director of Tianda Pharmaceuticals Ltd., effective Dec. 31.

Shaobin resigned to devote more time to his personal interests and has no disagreement with the company.